NCT05227547 Mapping and Characterization of Alveolar Cells During Smoking and Chronic Obstructive Disease
| NCT ID | NCT05227547 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Intercommunal Creteil |
| Condition | Chronic Obstructive Lung Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 186 participants |
| Start Date | 2022-10-05 |
| Primary Completion | 2030-10-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 186 participants in total. It began in 2022-10-05 with a primary completion date of 2030-10-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To evaluate the regenerative capacities of mesenchymal cells composing the microenvironment of alveolar type 2 cells in a population of patients, undergoing thoracic surgery for suspected cancer, who are smokers with and without COPD compared to non-smokers patients
Eligibility Criteria
Inclusion Criteria: 1. Age ≥ 18 2. Patient undergoing lung resection surgery (lobectomy, pneumonectomy, segmentectomy) for cancer or suspected cancer 3. Acceptance to participate in the protocol 4. Affiliated to a social security plan Exclusion Criteria: 1. Chronic autoimmune disease 2. Patient under guardianship or curators 3. Neo-adjuvant chemotherapy 4. History of thoracic radiotherapy 5. Pregnant woman 6. Minor patient 7. Person not able to consent 8. Person deprived of liberty
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05227547 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Obstructive Lung Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05227547 currently recruiting?
Yes, NCT05227547 is actively recruiting participants. Contact the research team at camille.jung@chiccreteil.fr for enrollment information.
Where is the NCT05227547 trial being conducted?
This trial is being conducted at Créteil, France, Paris, France, Paris, France, Paris, France.
Who is sponsoring the NCT05227547 clinical trial?
NCT05227547 is sponsored by Centre Hospitalier Intercommunal Creteil. The trial plans to enroll 186 participants.